This education resource supports the understanding of symptom control using subcutaneous medications at the end of life. This is most suitable for registered health care professionals who may be involved in the delivery, administration, or prescribing of subcutaneous medications at the end of life.
The learning objections for this session includes:
- Understand the situation regarding anticipatory syringe drivers in Cornwall
- Discuss symptoms that commonly arise in the last days to hours of life
- Identify reversible symptoms and appropriate management of them
- Recognise your competency and the importance of MDT decision making
- Understand the different prescribing principles of subcutaneous PRN medications and 24 hours syringe driver medications
- Summarise local guidelines for subcutaneous prescribing at EOL
- Understand the advantages and disadvantages of prescribing PRN subcutaneous medication in anticipation of symptoms often experienced at EOL
Please complete the following form to request access to this resource
Symptom Control Using Subcutaneous Medications at End of Life – Educational Resource – Request Form